Dr Jason Lee (Casino Addiction) Spends most time down Casino Gambling whilst Nigel Templeton committed suicide.
Do not trust these Dogs!
Bruce Kahn (Looks like Bruce needs an ankle bracelet)
He has been associated with mental health from the age of 25; He started with DPM (Diploma in Psychological medicine ) in India from CIP ranchi , then worked as a senior registrar at Amritsar India, during this period he cleared PLAB (Professional and linguistic board )to work and train in psychiatry in UK , He Completed MRCPsych and moved to Australia in end of 2009.John Reilly Megalomaniac and very Evil person.
Vera Old Bitch
Cheryl Dick Head EN
Steven Corney Dick Head
Di W. (SW)
Aroha Shuttleworth (CNC)
Darrelle Fat Bitch
Courtney-Lisa Dyer Perverting Course of Justice
Tom Phiri (Drug Injector)
Andrea Bitch EN Secure
Helen Reception Secure Bitch
John Baird (Narcissistic NAZI)
Charity Ghana Bitch
Allen Orr (Lazy}Michael Catt
Sivagnanam Agilan Drug Dealer
Lawrence Kozlowski Fuckwit
Jane Hay Slut
Anna Lazzari Bimbo
Aaron Little Liar
Sue Froggart Sickies
Dr Nissar Ahmed
Dr Adrian Morris Dickhead
Dr Tess Garrone
Fat Simba Samuriwo
Paul Cruickshank ( Witheld medication which led to 7 months in HDU )
Barry Graves Queensland Heath Security
Adam Queensland Health Security
Shannon Queensland Health Security
Did you know that if a psychiatrist diagnosis you with a mental disorder or mental health condition, then every psychiatrist who sees you after that first assessment, will diagnose you with a mental illness.
If you sit down with a doctor long enough they will eventually find something wrong with you.
Monday 30th November
Zuclopenthixol is a D1 and D2 antagonist, α1-adrenergic and 5-HT2 antagonist. While it is approved for use in Australia, Canada, Ireland, India, New Zealand, Singapore, South Africa and the UK it is not approved for use in the United States.
Chronic administration of zuclopenthixol (30 mg/kg/day for two years) in rats resulted in small, but significant, increases in the incidence of thyroid parafollicular carcinomas and, in females, of mammary adenocarcinomas and of pancreatic islet cell adenomas and carcinomas. An increase in the incidence of mammary adenocarcinomas is a common finding for D2 antagonists which increase prolactin secretion when administered to rats. An increase in the incidence of pancreatic islet cell tumours has been observed for some other D2 antagonists. The physiological differences between rats and humans with regard to prolactin make the clinical significance of these findings unclear.
Withdrawal syndrome: Abrupt cessation of therapy may cause acute withdrawal symptoms (eg, nausea, vomiting, or insomnia). Symptoms usually begin in 1 to 4 days of withdrawal and subside within 1 to 2 weeks.
Other permanent side effects are similar to many other typical antipsychotics, namely extrapyramidal symptoms as a result of dopamine blockade in subcortical areas of the brain. This may result in symptoms similar to those seen in Parkinson’s disease and include a restlessness and inability to sit still known as akathisia, a slow tremor and stiffness of the limbs. Zuclopenthixol is thought to be more sedating than the related flupentixol, though possibly less likely to induce extrapyramidal symptoms than other typical depots. As with other dopamine antagonists, zuclopenthixol may sometimes elevate prolactin levels; this may occasionally result in amenorrhoea or galactorrhoea in severe cases. Neuroleptic malignant syndrome is a rare but potentially fatal side effect. Any unexpected deterioration in mental state with confusion and muscle stiffness should be seen by a physician.
Zuclopenthixol decanoate induces a transient dose-dependent sedation. However, if the patient is switched to maintenance treatment with zuclopenthixol decanoate from oral zuclopenthixol or from i.m. zuclopenthixol acetate the sedation will be no problem. Tolerance to the unspecific sedative effect develops rapidly.Very common Adverse Effects (≥10% incidence) 
- Dry Mouth
Common (1%≤incidence≤10%) 
- Accommodation disorder
- Vision abnormal
- Salivary hypersecretion
- Pain (at the injection site)
- Increased appetite
- Weight gain
- Disturbance in attention
- Gait abnormal
- Abnormal dreams
- Libido decreased
- Nasal congestion
- Abdominal pain
- Injection site reaction
- Liver function test abnormal
- Decreased appetite
- Weight loss
- Muscle rigidity
- Tardive dyskinesia
- Speech disorder
- Libido increased
- Confusional state
- Ejaculation failure
- Erectile dysfunction
- Female orgasmic disorder
- Photosensitivity reaction
- Pigmentation disorder
- Hot flush
- Electrocardiogram QT prolonged
- Anaphylactic reaction
- Glucose tolerance impaired
- Withdrawal symptoms
Very rare (incidence<0.01%)
- Cholestatic hepatitis
- Neuroleptic malignant syndrome
- Venous thromboembolism
Getting it right the first time!
- Deprivation of liberty
- Perverting the cause of justice
- Administering a poison with intent to harm
- Assault with a deadly weapon
Dear Hon. Steven Miles
Firstly let me say that I appreciate the work of Karen and Gwen who have
spoken to me at length about my current situation.
I am experiencing complete displeasure from the current treatment I am
receiving from Queensland Health’s Mental Health services.
I am being bullied and taken advantage of by two Doctors, namely Dr
Sivagnanam Agilan and Dr Rupak Dasgupta.
It is bordering on mental torture the way I am being treated at present,
as I am not being listened to, nor are my human rights being acknowledged.
I write to you that my files are examined by your office, and that I be
placed on the inquiry for the hearing into Mental Health services in the
I would like this matter to be resolved in a timely manner and that I am
protected for speaking out against these Doctors.
I appreciate your time and look forward to your response.
AUSGovernment.com for all Australians!